Multiple sclerosis (MS) is a recurrent inflammatory disorder of the central nervous system
usually starting in early adult life. The cause and mechanisms of the disease remain mostly …

Multiple sclerosis (MS) is a chronic disease of the central nervous system with not yet
completely understood pathogenesis. The so called “chronic cerebrospinal venous …

The patient as an active participant in decision-making has become an important resource in
health care. Shared decision-making (SDM) relies on the patient's easy access to reliable …

Background It has been recently hypothesised that chronic cerebrospinal venous
insufficiency (CCSVI) may be an important factor in the pathogenesis of multiple sclerosis …

MULTIPLE SCLEROSIS (MS) IS A CHRONIC neurodegenerative disorder of un-known
cause. Inflammation, demy-elination, and neuroaxonal dysfunction contribute to its …

Introduction Initiating disease-modifying treatments (DMTs) in multiple sclerosis (MS) is a
major decision for people with (pw) MS but little is known about how the decision is …

As neurointerventionalists interested in interventional treatment of neurological disorders, it
is time to take a thorough and objective look at CCSVI. This commentary will examine the …

Cognitive difficulties in MS are widely acknowledged to have a major negative impact on the
lives of people with MS (PwMS). However they are viewed as “invisible” symptoms …

Background: Chronic cerebrospinal venous insufficiency (CCSVI) has been proposed to be
associated with multiple sclerosis (MS). Zamboni et al. reported significant improvement in …

CE INFORMATION ACTIVITY AVAILABLE ONLINE: To access the article and evaluation
online, go to https://www. highmarksce. com/mscare. TARGET AUDIENCE: The target …